|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | ||
| Restricted cash | ||
| Accounts receivable, net | ||
| Inventories | ||
| Prepayments, net | ||
| Deposits and other assets, net | ||
| Due from related parties | ||
| Total Current Assets | ||
| NON-CURRENT ASSETS | ||
| Property and equipment, net | ||
| Intangible assets, net | ||
| Deferred tax assets | ||
| Right-of-use assets | ||
| Goodwill | ||
| Prepayments - non current | ||
| Deposits and other assets - non current | ||
| Total Non-Current Assets | ||
| Total Assets | ||
| CURRENT LIABILITIES | ||
| Short-term bank loans | ||
| Tax payables | ||
| Salaries and benefits payable | ||
| Contract liability | ||
| Short-term lease liabilities | ||
| Accounts payable | ||
| Amounts due to a related party | ||
| Accrued listing expenses payable | ||
| Accrued expenses and other payables | ||
| Deferred tax liabilities | ||
| Long-term loan - current portion | ||
| Total Current Liabilities | ||
| NON-CURRENT LIABILITIES | ||
| Long-term lease liabilities | ||
| Long-term loan - non current | ||
| Total Non-Current Liabilities | ||
| Total Liabilities | ||
| Equity | ||
| Preferred shares, $0.0001 par value; 5,000,000 shares authorized; 290,000 shares issued and outstanding as of December 31, 2025 and 2024 | ||
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 40,979,382 shares issued, 30,752,370 shares outstanding as of December 31, 2025; 35,728,625 shares issued,25,555,096 shares outstanding as of December 31, 2024 | ||
| Additional paid-in capital | ||
| Statutory reserve | ||
| Retained earnings | ||
| Accumulated other comprehensive loss | ||
| Total Baird Medical Investment Holdings Limited's Shareholders' Equity | ||
| Non-controlling interests | ||
| Total Liabilities and Equity |
Loading...
